Integrated Biopharma, Inc.
INBP
$0.3069
$0.01194.03%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.46M | 2.27M | 1.68M | 2.02M | 732.00K |
| Total Receivables | 4.23M | 4.39M | 4.67M | 4.72M | 3.73M |
| Inventory | 11.07M | 11.22M | 11.24M | 11.17M | 12.15M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 398.00K | 432.00K | 286.00K | 353.00K | 451.00K |
| Total Current Assets | 18.15M | 18.31M | 17.88M | 18.26M | 17.07M |
|
|
|||||
| Total Current Assets | 18.15M | 18.31M | 17.88M | 18.26M | 17.07M |
| Net Property, Plant & Equipment | 3.09M | 3.41M | 3.68M | 3.91M | 3.81M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.41M | 4.46M | 4.66M | 4.77M | 4.85M |
| Total Assets | 25.66M | 26.18M | 26.21M | 26.94M | 25.72M |
|
|
|||||
| Total Accounts Payable | 2.81M | 2.76M | 2.51M | 3.67M | 3.31M |
| Total Accrued Expenses | 1.80M | 2.31M | 2.66M | 2.32M | 1.58M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 964.00K | 954.00K | 952.00K | 953.00K | 952.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 5.58M | 6.03M | 6.12M | 6.95M | 5.83M |
|
|
|||||
| Total Current Liabilities | 5.58M | 6.03M | 6.12M | 6.95M | 5.83M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 359.00K | 604.00K | 846.00K | 1.09M | 1.32M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.93M | 6.63M | 6.97M | 8.03M | 7.16M |
|
|
|||||
| Common Stock & APIC | 51.68M | 51.62M | 51.56M | 51.51M | 51.45M |
| Retained Earnings | -31.85M | -31.97M | -32.23M | -32.50M | -32.78M |
| Treasury Stock & Other | -99.00K | -99.00K | -99.00K | -99.00K | -99.00K |
| Total Common Equity | 19.73M | 19.55M | 19.24M | 18.91M | 18.57M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 19.73M | 19.55M | 19.24M | 18.91M | 18.57M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 19.73M | 19.55M | 19.24M | 18.91M | 18.57M |
|
|
|||||
